NCT04636671View on ClinicalTrials.gov

Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)

PHASE3CompletedINTERVENTIONAL
Enrollment

690

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

May 4, 2022

Study Completion Date

May 4, 2022

Conditions
Covid19Viral Pneumonia Human CoronavirusSevere Acute Respiratory Syndrome
Interventions
DRUG

Methylprednisolone

Per-protocol methylprednisolone administration and tapering (see arm description)

DRUG

Dexamethasone

Per-protocol dexamethasone administration (see arm description)

Trial Locations (1)

34149

Marco Confalonieri, Trieste

All Listed Sponsors
collaborator

Centro di Riferimento Oncologico - Aviano

OTHER

collaborator

National Institute for the Infectious Diseases (L. Spallanzani) - Rome

UNKNOWN

lead

University of Trieste

OTHER